KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $62.3 billion.

  • Amgen's Non-Current Assets fell 290.25% to $62.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $248.7 billion, marking a year-over-year decrease of 420.85%. This contributed to the annual value of $62.8 billion for FY2024, which is 600.55% down from last year.
  • Per Amgen's latest filing, its Non-Current Assets stood at $62.3 billion for Q3 2025, which was down 290.25% from $61.2 billion recorded in Q2 2025.
  • In the past 5 years, Amgen's Non-Current Assets ranged from a high of $66.8 billion in Q4 2023 and a low of $39.6 billion during Q3 2022
  • Over the past 5 years, Amgen's median Non-Current Assets value was $42.9 billion (recorded in 2022), while the average stood at $50.8 billion.
  • Its Non-Current Assets has fluctuated over the past 5 years, first surged by 5563.53% in 2023, then crashed by 600.55% in 2024.
  • Over the past 5 years, Amgen's Non-Current Assets (Quarter) stood at $41.8 billion in 2021, then grew by 2.76% to $42.9 billion in 2022, then surged by 55.64% to $66.8 billion in 2023, then fell by 6.01% to $62.8 billion in 2024, then fell by 0.88% to $62.3 billion in 2025.
  • Its Non-Current Assets was $62.3 billion in Q3 2025, compared to $61.2 billion in Q2 2025 and $62.4 billion in Q1 2025.